Literature DB >> 2866961

Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine.

D W Harron, R G Shanks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2866961     DOI： 10.1093/oxfordjournals.eurheartj.a061932

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 2.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

3.  On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.

Authors:  T Doerr; W Trautwein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

4.  Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.

Authors:  D W Harron; A H Deering; M Scott; M McMahon; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.